7 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
comparison between SGLT ... inhibitors - Canagliflozin ... (Invokana) - Dapagliflozin ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
CANVAS - Canagliflozin ... DECLARE-TIMI 58 - Dapagliflozin ... DAPA-CKD - Dapagliflozin ... DAPA-HF - Dapagliflozin ... #inhibitors #EBM
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Invokamet (metformin + canagliflozin ... Synjardy (metformin + empagliflozin ... Xigduo (metformin + dapagliflozin ... (linagliptin + empagliflozin ... ) • Qtern (dapagliflozin
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
gliflozin): • Empagliflozin ... the three • Dapagliflozin ... (Forxiga) • Canagliflozin ... loss (~2-3kg) • Empagliflozin ... and canagliflozin
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
In studies on canagliflozin ... (Invokana®), dapagliflozin ... type2diabetes, #canagliflozin ... , #dapagliflozin ... , #empagliflozin
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

CONCLUSIONS:
Among patients with heart failure and a
Dapagliflozin in ... those who received dapagliflozin ... or absence of diabetes ... Kosalan Akilan #Dapagliflozin ... #ebm
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... Medications • SGLT2i ... (Dapagliflozin) ... sarahthelyon #Diabetes